Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport

Neuron

Volumn 40, Issue 1, 2003, Pages 41-52

  Szebenyi, Györgyi ^a   Morfini, Gerardo A ^c,d   Babcock, Alyssa ^d   Gould, Milena ^d   Selkoe, Kimberly ^d   Stenoien, David L ^a,d   Young, Maureen ^b   Faber, Pieter W ^e,f   MacDonald, Marcy E ^e   McPhaul, Michael J ^b   Brady, Scott T ^c,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d MARINE BIOLOGICAL LABORATORY   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f ATHERSYS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; HUNTINGTIN; POLYGLUTAMINE; POLYPEPTIDE;

AMINO TERMINAL SEQUENCE; ARTICLE; AXOPLASM; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NERVE FIBER TRANSPORT; NEURITE; PRIORITY JOURNAL; PROTEIN FUNCTION;

EID: 10744224530     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(03)00569-5     Document Type: Article

References (58)

1. Amaratunga A., Morin P., Kosik K., Fine R. Inhibition of kinesin synthesis and rapid anterograde axonal transport in vivo by antisense oligonucleotide. J. Biol. Chem. 268:1993;17427-17430.
2. Block-Galarza J., Chase K.O., Sapp E., Vaughn K.T., Vallee R.B., DiFiglia M., Aronin N. Fast transport and retrograde movement of huntingtin and HAP 1 in axons. Neuroreport. 8:1997;2247-2251.
3. Brady S.T. Axonal dynamics and regeneration. Gorio A. Neuroregeneration. 1993;Raven Press, New York. 7-36.pp.
4. Brady S.T. Motor neuron diseases. interfering with the runners Nature. 375:1995;12-13.
5. Brady S.T. Neurofilaments run sprints not marathons. Nat. Cell Biol. 2:2000;E43-E45.
6. Brady S.T., Lasek R.J., Allen R.D. Video microscopy of fast axonal transport in isolated axoplasm. a new model for study of molecular mechanisms Cell Motil. 5:1985;81-101.
7. Brady S.T., Pfister K.K., Bloom G.S. A monoclonal antibody against kinesin inhibits both anterograde and retrograde fast axonal transport in squid axoplasm. Proc. Natl. Acad. Sci. USA. 87:1990;1061-1065.
8. Chen H.K., Fernandez-Funez P., Acevedo S.F., Lam Y.C., Kaytor M.D., Fernandez M.H., Aitken A., Skoulakis E.M., Orr H.T., Botas J., Zoghbi H.Y. Interaction of akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell. 113:2003;457-468.
9. DiFiglia M., Sapp E., Chase K., Schwarz C., Meloni A., Young C., Martin E., Vonsattel J.P., Carraway R., Reeves S.A.et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron. 14:1995;1075-1081.
10. Elluru R., Bloom G.S., Brady S.T. Fast axonal transport of kinesin in the rat visual system. functionality of the kinesin heavy chain isoforms Mol. Biol. Cell. 6:1995;21-40.
11. Emamian E.S., Kaytor M.D., Duvick L.A., Zu T., Tousey S.K., Zoghbi H.Y., Clark H.B., Orr H.T. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron. 38:2003;375-387.
12. Encinas M., Iglesias M., Liu Y., Wang H., Muhaisen A., Cena V., Gallego C., Comella J.X. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J. Neurochem. 75:2000;991-1003.
13. Faber P.W., Barnes G.T., Srinidhi J., Chen J., Gusella J.F., MacDonald M.E. Huntingtin interacts with a family of WW domain proteins. Hum. Mol. Genet. 7:1998;1463-1474.
14. Feiguin F., Ferreira A., Kosik K.S., Caceres A. Kinesin-mediated organelle translocation revealed by specific cellular manipulations. J. Cell Biol. 127:1994;1021-1039.
15. Ferhat L., Rami G., Medina I., Ben-Ari Y., Represa A. Process formation results from the imbalance between motor-mediated forces. J. Cell Sci. 114:2001;3899-3904.
16. Fischbeck K.H. Polyglutamine expansion neurodegenerative disease. Brain Res. Bull. 56:2001;161-163.
17. Goemaere-Vanneste J., Courad J.-Y., Hassig R., Di Giamberardino L., van den Bosch de Aguilar P. Reduced axonal transport of the G4 molecular form of acetylcholinesterase in the rat sciatic nerve during aging. J. Neurochem. 51:1988;1746-1754.
18. Grierson A.J., Shaw C.E., Miller C.C. Androgen induced cell death in SHSY5Y neuroblastoma cells expressing wild-type and spinal bulbar muscular atrophy mutant androgen receptors. Biochim. Biophys. Acta. 1536:2001;13-20.
19. Gusella J.F., MacDonald M.E. Molecular genetics. unmasking polyglutamine triggers in neurodegenerative disease Nat. Rev. Neurosci. 1:2000;109-115.
20. Hackam A.S., Singaraja R., Wellington C.L., Metzler M., McCutcheon K., Zhang T., Kalchman M., Hayden M.R. The influence of huntingtin protein size on nuclear localization and cellular toxicity. J. Cell Biol. 141:1998;1097-1105.
21. Hafezparast M., Klocke R., Ruhrberg C., Marquardt A., Ahmad-Annuar A., Bowen S., Lalli G., Witherden A.S., Hummerich H., Nicholson S.et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science. 300:2003;808-812.
22. Hughes R.E., Olson J.M. Therapeutic opportunities in polyglutamine disease. Nat. Med. 7:2001;419-423.
23. Huynh D.P., Figueroa K., Hoang N., Pulst S.M. Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nat. Genet. 26:2000;44-50.
24. Katsuno M., Adachi H., Kume A., Li M., Nakagomi Y., Niwa H., Sang C., Kobayashi Y., Doyu M., Sobue G. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron. 35:2002;843-854.
25. Lasek R.J., Brady S.T. Attachment of transported vesicles to microtubules in axoplasm is facilitated by AMP-PNP. Nature. 316:1985;645-647.
26. Li J.-Y., Pfister K.K., Brady S.T., Dahlström A. Cytoplasmic dynein conversion at a crush injury in rat peripheral axons. J. Neurosci. Res. 61:2000;151-161.
27. McQuarrie I.G., Brady S.T., Lasek R.J. Retardation in axonal transport of cytoskeletal elements during maturation and aging. Neurobiol. Aging. 10:1989;359-365.
28. Merry D.E., Kobayashi Y., Bailey C.K., Taye A.A., Fischbeck K.H. Cleavage, aggregation and toxicity of the expanded androgen receptor in spinal and bulbar muscular atrophy. Hum. Mol. Genet. 7:1998;693-701.
29. Morfini G., Szebenyi G., Elluru R., Ratner N., Brady S.T. Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J. 23:2002;281-293.
30. Morris J., Lasek R.J. Monomer-polymer equilibria in the axon. direct measurement of tubulin and actin as polymer and monomer in axoplasm J. Cell Biol. 98:1984;2064-2076.
31. Ordway J.M., Tallaksen-Greene S., Gutekunst C.A., Bernstein E.M., Cearley J.A., Wiener H.W., Dure IV L.S., Lindsey R., Hersch S.M., Jope R.S.et al. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell. 91:1997;753-763.
32. Orr H.T. Beyond the Qs in the polyglutamine diseases. Genes Dev. 15:2001;925-932.
33. Perez M.K., Paulson H.L., Pittman R.N. Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix. Hum. Mol. Genet. 8:1999;2377-2385.
34. Pestronk A., Drachman D.B., Griffin J.W. Effects of aging on nerve sprouting and regeneration. Exp. Neurol. 70:1980;65-82.
35. Pfister K.K., Wagner M.C., Stenoien D., Bloom G.S., Brady S.T. Monoclonal antibodies to kinesin heavy and light chains stain vesicle-like structures, but not microtubules, in cultured cells. J. Cell Biol. 108:1989;1453-1463.
36. Pfister K.K., Salata M.W., Dillman J.F., Vaughan K.T., Vallee R.B., Torre E., Lye R.J. Differential expression and phosphorylation of the 74-kDa intermediate chains of cytoplasmic dynein in cultured neurons and glia. J. Biol. Chem. 271:1996;1687-1694.
37. Piccioni F., Simeoni S., Andriola I., Armatura E., Bassanini S., Pozzi P., Poletti A. Polyglutamine tract expansion of the androgen receptor in a motoneuronal model of spinal and bulbar muscular atrophy. Brain Res. Bull. 56:2001;215-220.
38. Piccioni F., Pinton P., Simeoni S., Pozzi P., Fascio U., Vismara G., Martini L., Rizzuto R., Poletti A. Androgen receptor with elongated polyglutamine tract forms aggregates that alter axonal trafficking and mitochondrial distribution in motor neuronal processes. FASEB J. 16:2002;1418-1420.
39. Pigino G., Morfini G., Mattson M.P., Brady S.T., Busciglio J. Alzheimer's Presenilin 1 mutations impair kinesin-based axonal transport. J. Neurosci. 23:2003;4499-4508.
40. Ratner N., Bloom G.S., Brady S.T. A role for cdk5 kinase in fast anterograde axonal transport. novel effects of olomoucine and the APC tumor suppressor protein J. Neurosci. 18:1998;7717-7726.
41. Reddy P.H., Williams M., Tagle D.A. Recent advances in understanding the pathogenesis of Huntington's disease. Trends Neurosci. 22:1999;248-255.
42. Reid E., Kloos M., Ashley-Koch A., Hughes L., Bevan S., Svenson I.K., Graham F.L., Gaskell P.C., Dearlove A., Pericak-Vance M.A.et al. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am. J. Hum. Genet. 71:2002;1189-1194.
43. Rubinsztein D.C. Lessons from animal models of Huntington's disease. Trends Genet. 18:2002;202-209.
44. Sahenk Z., Mendell J., Brady S.T. Studies on the pathogenesis of vincristine-induced neuropathy. Muscle Nerve. 10:1986;80-84.
45. Schwab M.E. Structural plasticity of the adult CNS. Int. J. Dev. Neurosci. 14:1996;379-385.
46. Sharp A.H., Loev S.J., Schilling G., Li S.H., Li X.J., Bao J., Wagster M.V., Kotzuk J.A., Steiner J.P., Lo A.et al. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron. 14:1995;1065-1074.
47. Sickles D.W., Brady S.T., Testino A., Wrenn R.W. Direct effect of the neurotoxicant acrylamide on kinesin-based microtubule motility. J. Neurosci. Res. 46:1996;7-17.
48. Stenoien D.S., Brady S.T. Immunochemical analysis of kinesin light chain function. Mol. Biol. Cell. 8:1997;675-689.
49. Szebenyi G., Smith G.M., Li P., Brady S.T. Overexpression of neurofilament H disrupts normal cell structure and function. J. Neurosci. Res. 68:2002;185-198.
50. Takeyama K., Ito S., Yamamoto A., Tanimoto H., Furutani T., Kanuka H., Miura M., Tabata T., Kato S. Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron. 35:2002;855-864.
51. Trettel F., Rigamonti D., Hilditch-Maguire P., Wheeler V.C., Sharp A.H., Persichetti F., Cattaneo E., MacDonald M.E. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum. Mol. Genet. 9:2000;2799-2809.
52. Trottier Y., Devys D., Imbert G., Saudou F., An I., Lutz Y., Weber C., Agid Y., Hirsch E.C., Mandel J.L. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat. Genet. 10:1995;104-110.
53. Tsai M.-Y., Morfini G., Szebenyi G., Brady S.T. Modulation of kinesin-vesicle interactions by Hsc70. implications for regulation of fast axonal transport Mol. Biol. Cell. 11:2000;2161-2173.
54. Velier J., Kim M., Schwarz C., Kim T.W., Sapp E., Chase K., Aronin N., DiFiglia M. Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways. Exp. Neurol. 152:1998;34-40.
55. Wellington C.L., Ellerby L.M., Hackam A.S., Margolis R.L., Trifiro M.A., Singaraja R., McCutcheon K., Salvesen G.S., Propp S.S., Bromm M.et al. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem. 273:1998;9158-9167.
56. Wieacker P.F., Knoke I., Jakubiczka S. Clinical and molecular aspects of androgen receptor defects. Exp. Clin. Endocrinol. Diabetes. 106:1998;446-453.
57. Zhao C., Takita J., Tanaka Y., Setou M., Nakagawa T., Takeda S., Yang H.W., Terada S., Nakata T., Takei Y.et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell. 105:2001;587-597.
58. Zoghbi H.Y., Orr H.T. Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23:2000;217-247.